<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02780000_1</Organism_ID>
  <Organism>Salmonella typhimurium</Organism>
  <Organism_Latin>Salmonella typhimurium</Organism_Latin>
  <UniProt_ID>P20506</UniProt_ID>
  <Seq_Length>514</Seq_Length>
  <Molecule_Weight>56253</Molecule_Weight>
  <KEGG_ID>stm:STM3905</KEGG_ID>
  <Orthology_ID>K01754</Orthology_ID>
  <Function_Summary>Catalyzes the anaerobic formation of alpha-ketobutyrate and ammonia from threonine in a two-step reaction. The first step involved a dehydration of threonine and a production of enamine intermediates (aminocrotonate), which tautomerizes to its imine form (iminobutyrate). Both intermediates are unstable and short-lived. The second step is the nonenzymatic hydrolysis of the enamine/imine intermediates to form 2-ketobutyrate and free ammonia. In the low water environment of the cell, the second step is accelerated by RidA (By similarity).</Function_Summary>
  <Catalytic_Mechanism>L-threonine = 2-oxobutanoate + NH(3).</Catalytic_Mechanism>
  <Pfam_ID>PF00291:PALP@@PF00585:Thr_dehydrat_C</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Threonine deaminase</Alias>
      <Alias>Threonine dehydratase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.</Detail>
      <Keyword>Pyridoxal phosphate binding</Keyword>
      <Ontology_ID>GO:0030170</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the cleavage of C-C, C-O, C-N and other bonds by other means than by hydrolysis or oxidation, or conversely adding a group to a double bond. They differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.</Detail>
      <Keyword>Lyase activity</Keyword>
      <Ontology_ID>GO:0016829</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: L-threonine = 2-oxobutanoate + NH3.</Detail>
      <Keyword>L-threonine ammonia-lyase activity</Keyword>
      <Ontology_ID>GO:0004794</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of amino acids, organic acids containing one or more amino substituents.</Detail>
      <Keyword>Cellular amino acid biosynthetic process</Keyword>
      <Ontology_ID>GO:0008652</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.</Detail>
      <Keyword>Isoleucine biosynthetic process</Keyword>
      <Ontology_ID>GO:0009097</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving threonine (2-amino-3-hydroxybutyric acid), a polar, uncharged, essential amino acid found in peptide linkage in proteins.</Detail>
      <Keyword>Threonine metabolic process</Keyword>
      <Ontology_ID>GO:0006566</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.</Detail>
      <Keyword>Branched chain family amino acid biosynthetic process</Keyword>
      <Ontology_ID>GO:0009082</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>62</Position>
      <PTM_Type>N6-(pyridoxal phosphate)lysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAESQPLSVAPEGAEYLRAVLRAPVYEAAQVTPLQKMEKLSSRLDNVILVKREDRQPVHSFKLRGAYAMMAGLTEEQKAHGVITASAGNHAQGVAFSSARLGVKSLIVMPKATADIKVDAVRGFGGEVLLHGANFDEAKAKAIELAQQQGFTWVPPFDHPMVIAGQGTLALELLQQDSHLDRVFVPVGGGGLAAGVAVLIKQLMPQIKVIAVEAEDSACLKAALEAGHPVDLPRVGLFAEGVAVKRIGDETFRLCQEYLDDIITVDSDAICAAMKDLFEDVRAVAEPSGALALAGMKKYIAQHNIRGERLAHVLSGANVNFHGLRYVSERCELGEQREALLAVTIPEEKGSFLKFCQLLGGRMVTEFNYRFADAKNACIFVGVRVSQGLEERKEIITQLCDGGYSVVDLSDDEMAKLHVRYMVGGRPSKPLQERLYSFEFPESPGALLKFLHTLGTHWNISLFHYRSHGTDYGRVLAAFELGDHEPDFETRLHELGYECHDESNNPAFRFFLAG</Protein_Seq>
  </Molecule_Seq>
  <Gene>
    <Gene_Name>ilvA</Gene_Name>
    <Gene_ID>1255431</Gene_ID>
    <Genbank_ACCN>NC_003197</Genbank_ACCN>
    <Protein_ACCN>NP_462796</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1255431</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of dimeric biodegradative threonine deaminase (TdcB) from Salmonella typhimurium at 1.7 A resolution (Triclinic form with one complete subunit built in alternate conformation)</PDB_Title>
      <PDB_ID>2GN0</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GN0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of Salmonella typhimurium biodegradative threonine deaminase and its complex with CMP provide structural insights into ligand-induced oligomerization and enzyme activation.</PubMed_Title>
      <Author>Simanshu DK, et al.</Author>
      <Journal>J Biol Chem. 2006 Dec 22;281(51):39630-41. Epub 2006 Oct 17.</Journal>
      <PubMed_ID>17046821</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of dimeric biodegradative threonine deaminase (TdcB) from Salmonella typhimurium at 2.2A resolution (Triclinic form with one dimer of TdcB in the asymmetric unit)</PDB_Title>
      <PDB_ID>2GN1</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GN1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of Salmonella typhimurium biodegradative threonine deaminase and its complex with CMP provide structural insights into ligand-induced oligomerization and enzyme activation.</PubMed_Title>
      <Author>Simanshu DK, et al.</Author>
      <Journal>J Biol Chem. 2006 Dec 22;281(51):39630-41. Epub 2006 Oct 18.</Journal>
      <PubMed_ID>17046822</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of tetrameric biodegradative threonine deaminase (TdcB) from Salmonella typhimurium in complex with CMP at 2.5A resolution (Hexagonal form)</PDB_Title>
      <PDB_ID>2GN2</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GN2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>CYTIDINE-5'-MONOPHOSPHATE</Ligand_Name>
      <PubMed_Title>Crystal structures of Salmonella typhimurium biodegradative threonine deaminase and its complex with CMP provide structural insights into ligand-induced oligomerization and enzyme activation.</PubMed_Title>
      <Author>Simanshu DK, et al.</Author>
      <Journal>J Biol Chem. 2006 Dec 22;281(51):39630-41. Epub 2006 Oct 19.</Journal>
      <PubMed_ID>17046823</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00290</Pathway_ID>
      <Pathway_Title>Valine, leucine and isoleucine biosynthesis</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00260</Pathway_ID>
      <Pathway_Title>Glycine, serine and threonine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00260</Pathway_ID>
      <Pathway_Title>Glycine, serine and threonine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Amino acid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Blatt JM, et al. Biochim.Biophys.Acta. 1978,526(1):267-275.;Selwood T, et al. Arch Biochem Biophys. 2012, 519(2):131-143.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PubMed_ID>356889;22182754</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>4.3.1.19</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC4/3/1/19.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00030001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00210001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00490001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00860002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00860008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02780002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>